These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 9627686)
1. Pharmacology and molecular action of retinoids and vitamin D in skin. Kang S; Li XY; Voorhees JJ J Investig Dermatol Symp Proc; 1996 Apr; 1(1):15-21. PubMed ID: 9627686 [TBL] [Abstract][Full Text] [Related]
2. Interaction between retinoic acid and vitamin D signaling pathways. Schräder M; Bendik I; Becker-André M; Carlberg C J Biol Chem; 1993 Aug; 268(24):17830-6. PubMed ID: 8394351 [TBL] [Abstract][Full Text] [Related]
3. Retinoid X receptor-specific ligands synergistically upregulate 1, 25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo. Li XY; Xiao JH; Feng X; Qin L; Voorhees JJ J Invest Dermatol; 1997 Apr; 108(4):506-12. PubMed ID: 9077482 [TBL] [Abstract][Full Text] [Related]
4. Vitamin D represses retinoic acid-dependent transactivation of the retinoic acid receptor-beta2 promoter: the AF-2 domain of the vitamin D receptor is required for transrepression. Jiménez-Lara AM; Aranda A Endocrinology; 1999 Jun; 140(6):2898-907. PubMed ID: 10342883 [TBL] [Abstract][Full Text] [Related]
5. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related]
6. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells. Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors. Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913 [TBL] [Abstract][Full Text] [Related]
8. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo. Lemon BD; Freedman LP Mol Cell Biol; 1996 Mar; 16(3):1006-16. PubMed ID: 8622645 [TBL] [Abstract][Full Text] [Related]
9. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation. Matkovits T; Christakos S Mol Endocrinol; 1995 Feb; 9(2):232-42. PubMed ID: 7776973 [TBL] [Abstract][Full Text] [Related]
10. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883 [TBL] [Abstract][Full Text] [Related]
11. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469 [TBL] [Abstract][Full Text] [Related]
12. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements. Kimmel-Jehan C; Darwish HM; Strugnell SA; Jehan F; Wiefling B; DeLuca HF J Cell Biochem; 1999 Aug; 74(2):220-8. PubMed ID: 10404392 [TBL] [Abstract][Full Text] [Related]
13. [Retinoids: mechanisms of action]. Berbis P Ann Dermatol Venereol; 2010 Nov; 137 Suppl 3():S97-103. PubMed ID: 21185985 [TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M; Freedman LP; Li H; Christakos S Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705 [TBL] [Abstract][Full Text] [Related]
15. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action. Nezbedova P; Brtko J Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236 [TBL] [Abstract][Full Text] [Related]
16. Specificity and flexibility of vitamin D signaling. Modulation of the activation of natural vitamin D response elements by thyroid hormone. Schräder M; Müller KM; Carlberg C J Biol Chem; 1994 Feb; 269(8):5501-4. PubMed ID: 8119880 [TBL] [Abstract][Full Text] [Related]
17. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids. Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993 [TBL] [Abstract][Full Text] [Related]
18. Expression of vitamin D3 receptor and retinoid receptors in human breast cancer: identification of potential heterodimeric receptors. Conde I; Paniagua R; Fraile B; Ruiz A; Arenas MI Int J Oncol; 2004 Oct; 25(4):1183-91. PubMed ID: 15375571 [TBL] [Abstract][Full Text] [Related]
19. Lipid soluble vitamins in gene regulation. Carlberg C Biofactors; 1999; 10(2-3):91-7. PubMed ID: 10609868 [TBL] [Abstract][Full Text] [Related]
20. [Gene structure and transcriptional regulation of vitamin A, D binding proteins and nuclear receptors]. Takeyama K; Kato S Nihon Rinsho; 1999 Oct; 57(10):2284-94. PubMed ID: 10540875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]